Lupin gets tentative nod from USFDA to market type 2 diabetes drug
Lupin gets tentative nod from USFDA to market type 2 diabetes drug The product is a generic version of Boehringer Ingelheim Pharmaceuticals Inc's Glyxambi tablets in the same strengths, Lupin said in a statement. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment